Professor of Pharmacology and Neurosciences
Université de Montréal
Montréal, Quebec, Canada
Dr. Trudeau received a B.Sc. in psychology from Concordia University in Montreal in 1990 and a M.Sc. in neuroscience from the Université Pierre et Marie Curie in Paris in 1991, working with Aplysia model system pioneer Ladislav Tauc. He then obtained his Ph.D. in neuroscience from the Université de Montréal in 1994, working with Vincent Castelluccci on the synaptic mechanisms underlying memory formation in Aplysia. He subsequently pursued postdoctoral training at Iowa State University until 1997, working with Phil Haydon on some of the elementary mechanisms of synaptic plasticity in rat hippocampal neurons. Dr. Trudeau was recruited back at the Université de Montréal in 1997 and is currently full professor of pharmacology and neurosciences at the Université de Montréal Faculty of Medicine. He has obtained numerous salary awards and research grants from the Canadian Institutes of Health Research, Neuroscience Canada, the Fonds de la Recherche en Santé du Québec, the EJLB Foundation, Brain Canada, The Miachel J Fox Foundation for Parkinson’s research and Parkinson Society Canada. He has published over 90 peer-reviewed articles. His main research interests concern the mechanisms that control neurotransmitter release, connectivity and vulnerability of dopamine-containing neurons in the brain. His laboratory has made numerous contributions to our understanding of the ability of dopamine neurons to use glutamate as a co-transmitter, on the functions of dopamine autoreceptors and more recently on the origin of the selective vulnerability of dopamine neurons.